NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 50268-0627-15 — Oxybutynin 5 mg extended-release tabletAI (222 hospitals, 27,112–27,625 samples)
• NDC 68001-0362-06 — Cefdinir 300 mg oral capsulesAI (267 hospitals, 27,064–27,622 samples)
• NDC 55150-0125-02 — Ondansetron 4 mg/2 mL injectionAI (287 hospitals, 26,464–27,616 samples)
• NDC 63739-0548-33 — Oxybutynin 5 mg extended-release tabletAI (212 hospitals, 27,111–27,615 samples)
• NDC 81033-0020-50 — Mupirocin 2% ointmentAI (218 hospitals, 26,642–27,614 samples)
• NDC 00008-0923-60 — Pantoprazole 40 mg intravenous injectionAI (332 hospitals, 25,875–27,612 samples)
• NDC 00781-3208-85 — Ceftriaxone sodium injection 1 gramAI (427 hospitals, 17,261–27,593 samples)
• NDC 60505-1003-02 — Ketorolac eye drops, 10 mL bottleAI (242 hospitals, 26,563–27,580 samples)
• NDC 72485-0670-35 — Erythromycin eye ointmentAI (239 hospitals, 26,306–27,575 samples)
• NDC 49884-0724-01 — Hydroxyurea 500 mg capsulesAI (624 hospitals, 26,922–27,561 samples)
• NDC 33342-0083-07 — Olanzapine orally disintegrating tablet, 5 mgAI (384 hospitals, 26,996–27,536 samples)
• NDC 00093-2210-01 — Sucralfate 1 gram tabletAI (546 hospitals, 26,848–27,532 samples)
• NDC 44567-0641-10 — Unclassified or miscellaneous drugAI (178 hospitals, 26,668–27,523 samples)
• NDC 63323-0664-01 — Diphenhydramine 50 mg/mL injectionAI (970 hospitals, 20,246–27,518 samples)
• NDC 50268-0621-11 — Ondansetron 4 mg oral tabletsAI (219 hospitals, 23,305–27,517 samples)
• NDC 45802-0210-01 — Nitroglycerin spray, 0.4 mg per doseAI (619 hospitals, 26,232–27,501 samples)
• NDC 65219-0289-65 — GADOBUTROL 1 MMOL/ML (604.72 MG/ML) INTRAVENOUS SOLUTION (7 hospitals, 27,498 samples)
• NDC 65219-0287-30 — GADOBUTROL 1 MMOL/ML IV SOLN (7 hospitals, 27,498 samples)
• NDC 61314-0044-75 — Trifluridine 1% eye dropsAI (799 hospitals, 26,559–27,495 samples)
• NDC 65862-0560-90 — Pantoprazole 40 mg delayed-release tabletAI (282 hospitals, 26,807–27,491 samples)
• NDC 68084-0093-01 — Carbidopa-levodopa 25/100 mg oral tabletsAI (218 hospitals, 27,005–27,482 samples)
• NDC 44567-0708-10 — Cefazolin 10 gram injection solutionAI (232 hospitals, 25,542–27,477 samples)
• NDC 00409-2305-04 — Midazolam injection, 1 mg/mLAI (363 hospitals, 24,309–27,468 samples)
• NDC 82182-0773-05 — BRIMONIDINE 0.15 % EYE DROPSAI (221 hospitals, 26,613–27,468 samples)
• NDC 70069-0746-25 — Potassium phosphate intravenous solutionAI (105 hospitals, 26,540–27,458 samples)
• NDC 00143-9633-01 — Nicardipine intravenous infusion, 40 mg in 200 mL salineAI (315 hospitals, 25,554–27,453 samples)
• NDC 42192-0608-06 — Gabapentin 300 mg/6 mL oral solutionAI (394 hospitals, 26,894–27,452 samples)
• NDC 51991-0759-33 — letrozole 2.5 mg tabletAI (460 hospitals, 26,623–27,451 samples)
• NDC 16571-0723-60 — Mafenide acetate cream 85 mg/g, 56.7 g tubeAI (328 hospitals, 26,437–27,445 samples)
• NDC 10122-0325-10 — Nicardipine in sodium chloride premixed IV bagAI (225 hospitals, 25,454–27,443 samples)
• NDC 70408-0239-32 — Nitrofurantoin oral liquid, 25 mg per 5 mLAI (267 hospitals, 26,515–27,442 samples)
• NDC 00409-1560-19 — Bupivacaine 0.5% preservative-free injectionAI (200 hospitals, 26,136–27,432 samples)
• NDC 00781-7077-87 — Metronidazole vaginal gel 0.75%AI (246 hospitals, 26,530–27,430 samples)
• NDC 00143-9680-01 — Glycopyrrolate injectionAI (262 hospitals, 25,242–27,429 samples)
• NDC 00338-1137-03 — Amino acid and dextrose intravenous solutionAI (291 hospitals, 27,113–27,419 samples)
• NDC 45802-0056-35 — Gentamicin 0.1% cream, 15 g tubeAI (775 hospitals, 26,384–27,410 samples)
• NDC 70752-0113-03 — Lidocaine 5% ointmentAI (372 hospitals, 26,387–27,395 samples)
• NDC 63323-0924-10 — Bacteriostatic saline injectionAI (362 hospitals, 26,990–27,386 samples)
• NDC 39822-3030-02 — Pentamidine inhaled solution 300 mgAI (200 hospitals, 26,023–27,382 samples)
• NDC 63323-0485-27 — Xylocaine 1% injection solutionAI (675 hospitals, 22,568–27,365 samples)
• NDC 00338-9543-05 — Sodium chloride 0.9% intravenous fluid bagAI (153 hospitals, 27,130–27,364 samples)
• NDC 00409-1966-02 — Bacteriostatic sodium chloride 0.9% injectionAI (310 hospitals, 26,959–27,355 samples)
• NDC 66689-0023-50 — Hydrocodone-acetaminophen liquid medicine, 15 mL cupAI (295 hospitals, 26,792–27,341 samples)
• NDC 00990-7120-07 — Dextrose 70% intravenous solutionAI (222 hospitals, 26,960–27,338 samples)
• NDC 63323-0412-10 — Midazolam 1 mg/mL vialAI (287 hospitals, 24,436–27,325 samples)
• NDC 50742-0549-05 — Fentanyl 12 mcg/hr skin patchAI (129 hospitals, 26,464–27,319 samples)
• NDC 65219-0534-01 — Tranexamic acid IV infusion, 1,000 mgAI (91 hospitals, 26,515–27,316 samples)
• NDC 60505-0560-00 — Ofloxacin 0.3% eye dropsAI (429 hospitals, 26,234–27,305 samples)
• NDC 70092-1030-36 — Midazolam in saline bag, 100 mLAI (207 hospitals, 25,487–27,305 samples)
• NDC 65219-0383-06 — Iodixanol 320 contrast injectionAI (105 hospitals, 25,954–27,295 samples)